MORELLO JAMES J 4
4 · PROASSURANCE CORP · Filed Sep 9, 2004
Insider Transaction Report
Form 4
MORELLO JAMES J
TreasurerOther
Transactions
- Tax Payment
Common Stock
2004-09-07$34.53/sh−9,958$343,850→ 25,115 total - Exercise/Conversion
Common Stock
2004-09-07$34.53/sh+16,000$552,480→ 35,073 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-09-07+16,000→ 16,000 totalExercise: $16.80From: 2002-07-15Exp: 2012-01-15→ Common Stock (16,000 underlying)
Holdings
- 2,480
Employee Stock Option (Right to Buy)
Exercise: $26.03From: 2001-06-27Exp: 2008-12-01→ Common Stock (2,480 underlying) - 4,755(indirect: Shares held in the ProAssurance Group Savings and Retirement Plan)
Common Stock
- 3,148(indirect: By IRA)
Common Stock
- 12,500
Employee Stock Option (Right to Buy)
Exercise: $33.28From: 2004-09-10Exp: 2014-09-10→ Common Stock (12,500 underlying) - 2,403
Employee Stock Option (Right to Buy)
Exercise: $21.01From: 2001-06-27Exp: 2009-12-09→ Common Stock (2,403 underlying) - 3,067
Employee Stock Option (Right to Buy)
Exercise: $24.68From: 2001-06-27Exp: 2007-12-02→ Common Stock (3,067 underlying)
Footnotes (6)
- [F1]Cashless exercise of options on 9/7/2004
- [F2]The 9,958 shares disposed of reflect 7,785 shares withheld by the issuer to fund the cashless exercise of 16,000 options on 9/07/04, and 2,173 shares withheld by the issuer to cover the associated tax liability.
- [F3]The options vest in five equal installments commencing on September 10, 2004
- [F4]The options vest in five equal installments commencing on September 4, 2003
- [F5]The options vest in five equal installments commencing on July 15, 2002
- [F6]Reflects options to purchase shares of ProAssurance Corporation common stock acquired beneficially by the reporting person in exchange for surrender of options to purchase shares of Medical Assurance, Inc. in connection with the consolidation of Medical Assurance, Inc. and Professionals group under the ownership of ProAssurance Corporation. The acquisition of options to purchase ProAssurance shares reported herein is exempt from Section 16(b) of the Securities Exchange Act, as amended (the "Act"), by virtue of Rule 16b-3(d) promulgated under the Act.